Exchange Traded Concepts, LLC Novavax Inc Transaction History

Exchange Traded Concepts, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$36.28 - $75.29 $33,196 - $68,890	915 New	915 $47,000
Q1 2022 Apr 26, 2022	SELL	$69.73 - $142.9 $36,468 - $74,736	-523 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$134.56 - $217.97 $70,374 - $113,998	523 New	523 $75,000
Q2 2021 Jul 30, 2021	SELL	$121.0 - $257.67 $93,654 - $199,436	-774 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$112.98 - $319.93 $69,256 - $196,117	-613 Reduced 44.2%	774 $140,000
Q4 2020 Jan 19, 2021	BUY	$78.74 - $139.5 $109,212 - $193,486	1,387 New	1,387 $155,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.